Market closedNon-fractional

XBiotech/XBIT

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX

About XBiotech

XBiotech Inc is a United States-based clinical-stage biopharmaceutical company. It is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-IL-1 a therapeutic antibody as a treatment for cancer. Geographically, all of its operations are in the United States.

Ticker

XBIT

Sector

Healthcare

Trading on

NASDAQ

Industry

Biotechnology

Headquarters

Austin, United States

Employees

92

XBiotech Metrics

BasicAdvanced
$174M
Market cap
-
P/E ratio
-$1.01
EPS
1.49
Beta
-
Dividend rate
$174M
1.49
12.027
11.963
4.778
-206.09%
-10.96%
-13.78%
0.84
0.84
-7.985
-1.53%
28.93%

XBiotech Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
0.00% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$0
NaN%
Net income
-$10M
117.39%
Profit margin
0.00%
NaN%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional

Upcoming events

No upcoming events

FAQs

What’s the current market cap for XBiotech stock?

XBiotech (XBIT) has a market cap of $174M as of July 06, 2024.

What is the P/E ratio for XBiotech stock?

The price to earnings (P/E) ratio for XBiotech (XBIT) stock is 0 as of July 06, 2024.

Does XBiotech stock pay dividends?

No, XBiotech (XBIT) stock does not pay dividends to its shareholders as of July 06, 2024.

When is the next XBiotech dividend payment date?

XBiotech (XBIT) stock does not pay dividends to its shareholders.

What is the beta indicator for XBiotech?

XBiotech (XBIT) has a beta rating of 1.49. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.

Buy or sell XBiotech stock

Buy or sell XBiotech stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing